PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.40%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-29.55%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-62.46%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-62.46%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-63.67%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-65.79%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-64.86%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
2.06%
Slight or no buybacks while MU is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-12.19%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-2.02%
Dividend reduction while MU stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-81.83%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-145.60%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
9.31%
10Y revenue/share CAGR under 50% of MU's 1115.61%. Michael Burry would suspect a lasting competitive disadvantage.
-19.03%
Negative 5Y CAGR while MU stands at 15.35%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
1.93%
3Y revenue/share CAGR under 50% of MU's 7.20%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
72.96%
10Y OCF/share CAGR under 50% of MU's 1953.37%. Michael Burry would worry about a persistent underperformance in cash creation.
241.61%
Positive OCF/share growth while MU is negative. John Neff might see a comparative advantage in operational cash viability.
333.18%
3Y OCF/share CAGR above 1.5x MU's 82.05%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
403.33%
Below 50% of MU's 2117.53%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
20.89%
Positive 5Y CAGR while MU is negative. John Neff might view this as a strong mid-term relative advantage.
1743.73%
3Y net income/share CAGR 75-90% of MU's 1949.05%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
305.24%
Below 50% of MU's 739.68%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
163.29%
5Y equity/share CAGR is in line with MU's 151.24%. Walter Schloss would see parallel mid-term profitability and retention policies.
91.82%
3Y equity/share CAGR above 1.5x MU's 44.56%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
5.40%
Dividend/share CAGR of 5.40% while MU is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-0.94%
Negative 5Y dividend/share CAGR while MU stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-1.13%
Negative near-term dividend growth while MU invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-11.62%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-4.30%
Inventory is declining while MU stands at 45.63%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.70%
Negative asset growth while MU invests at 1.77%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.20%
Under 50% of MU's 17.78%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.60%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
1.13%
R&D dropping or stable vs. MU's 5.92%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-13.22%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.